Japan Pharma Outlook
Japan Pharma Outlook
$3,000.00
Datamonitor’s Japan Pharma peer set contains the top 10 companies headquartered in Japan: Takeda Pharmaceuticals, Astellas Pharma, Daiichi Sankyo, Otsuka Pharmaceutical, Eisai, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Dainippon Sumitomo, Shionogi & Co and Kyowa Hakko Kirin.
Author: John Bird
Publisher: Datamonitor Healthcare
- Description
Limited domestic sales growth opportunities lead to an increasingly global strategy.
Japan’s pharmaceutical industry is in the midst of a defining period. The sector has evolved dramatically over the past decade, as companies attempt to gain ground on their Western peers in meeting the demands of global healthcare markets.
While the top 10 companies in Japan Pharma are dominant within their domestic market, generating more than half of overall prescription pharma revenues in Japan, a range of factors have provided the impetus for companies to expand their global footprint.
Datamonitor’s Japan Pharma peer set contains the top 10 companies headquartered in Japan:
Takeda Pharmaceuticals Co., Ltd
Astellas Pharma Inc.
Daiichi Sankyo Co., Ltd
Otsuka Pharmaceutical Co., Ltd
Eisai Co., Ltd
Mitsubishi Tanabe Pharma Corp.
Chugai Pharmaceutical Co., Ltd
Dainippon Sumitomo Ph. Co., Ltd
Shionogi & Co., Ltd
Kyowa Hakko Kirin Co., Ltd
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Teflaro 
Sign up to the